Zobrazeno 1 - 10
of 114
pro vyhledávání: '"A. A. Kudrjavtseva"'
Autor:
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 4, Pp 401-408 (2024)
Aim. To assess the compliance of nephroprotective and anticoagulant therapy in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) with modern clinical guidelines.Material and methods. The study included patients with CKD in combi
Externí odkaz:
https://doaj.org/article/045088b52f354983b8aa8acc83d0ea18
Autor:
D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 2, Pp 221-226 (2024)
Aim. To study the effect of dietary supplements containing omega-3 polyunsaturated fatty acids (Omega-3 PUFAs) on the parameters of ambulatory blood pressure monitoring (ABPM), 24-hour electrocardiogram (HM-ECG), and lipid profile in postmenopausal w
Externí odkaz:
https://doaj.org/article/08419b7fee4141cda8e2eac35faedac3
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 3S (2024)
Chronic kidney disease is one of the most important diseases in comorbid patients with cardiovascular disease. To reduce the risk of cardiovascular and renal complications, such patients should receive renin-angiotensin system inhibitors, statins and
Externí odkaz:
https://doaj.org/article/4f0c92139e13457ba5bb04e058e3a03e
Autor:
Z. A. Gebekova, I. I. Ivanov, A. A. Kudrjavtseva, E. V. Kolpachkova, A. A. Sokolova, V. P. Sedov, D. A. Napalkov
Publikováno v:
Атеротромбоз, Vol 12, Iss 2, Pp 103-112 (2023)
Thromboembolic syndrome, the frequency of which is 8–15%, is the main danger for a patient with atrial fibrillation (AF). The left atrial appendage is the most common source of thromboembolia in atrial fibrillation. The frequency of detection of le
Externí odkaz:
https://doaj.org/article/efa6b7b95cef45c99220eb021c0f307e
Autor:
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 3, Pp 350-355 (2018)
The article presents a clinical observation of the left atrial appendage thrombosis in a 51-year-old female patient with a paroxysmal form of nonvalvular atrial fibrillation which occurred despite long-term anticoagulant therapy with apixaban in a fu
Externí odkaz:
https://doaj.org/article/73b0a0385bf44365bc2802d3e6e61852
Publikováno v:
Linguistica Uralica. LI(3):231-235
Externí odkaz:
https://www.ceeol.com/search/article-detail?id=281386
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 42
Aim is to compare the phenotypes of vascular aging (VA) in young people with manifestations of hereditary connective tissue disorders (HCTD), which are increasingly common in modern youth. Material and Methods: 264 students (93 boys and 171 girls) we
Autor:
Maria Evsevyeva, Michail Eremin, oxana sergeeva, MARIA ROSTOVTSEVA, Evgeny Shchetinin, Victoria Kudrjavtseva
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 41
Background: The phenomenon of the" paradox " of obesity has been studied mainly in the elderly and even senile population in the presence of one or another obvious cardiovascular pathology, usually in combination with various complications. The study
Autor:
Irina Gachkova, Maria Evsevyeva, M. Rostovtseva, Victoria Kudrjavtseva, Michail Eremin, Ilona Galkova
Publikováno v:
Hypertension. 78
Background: The relationship of arterial stiffness, which is marker of vascular age, with the main risk factors (RF) was studied mainly in adults and elderly. Purpose - to evaluate associations of various body mass (BM) with vascular stiffness, blood
Autor:
M.I. Korabelnikova, Kuzin Sn, Semenenko Ta, N.F. Gamaleya Nrcem, Moscow, Russia, Ya V. Panasyuk, E.N. Kudrjavtseva
Publikováno v:
Molecular Diagnostics and Biosafety – 2020. Russian national scientific and practical conference with international participation (October, 6–8, 2020): Conference Proceedings.
In the studied cohort, HCV subtypes 1b and 3a prevailed — 47,7% and 38,9%, respectively HCV genotype 2 was detected in 7,2% of cases and HCV subtype 1a — in 5,8% of cases. HCV genotype was not determined in 0,4% of patients. Difference between a